Inflammatory bowel disease: the role of inflammatory cytokine gene polymorphisms

• Main Authors: Joanna Balding, Wendy J. Livingstone, Judith Conroy, Lesley Mynett-Johnson, Donald G. Weir, Nasir Mahmud, Owen P. Smith
• Format: Article
• Language: English
• Published: Hindawi Limited 2004-01-01
• Series: Mediators of Inflammation
• Subjects: Inflammatory bowel disease; Cytokine; Polymorphism.
• Online Access: http://dx.doi.org/10.1080/09511920410001713529

THE mechanisms responsible for development of inflammatory bowel disease (IBD) have not been fully elucidated, although the main cause of disease pathology is attributed to up-regulated inflammatory processes. The aim of this study was to investigate frequencies of polymorphisms in genes encoding pro-inflammatory and anti-inflammatory markers in IBD patients and controls. We determined genotypes of patients with IBD (n=172) and healthy controls (n=389) for polymorphisms in genes encoding various cytokines (interleukin (IL)-1β, IL-6, tumour necrosis factor (TNF), IL-10, IL-1 receptor antagonist). Association of these genotypes to disease incidence and pathophysiology was investigated. No strong association was found with occurrence of IBD. Variation was observed between the ulcerative colitis study group and the control population for the TNF-α-308 polymorphism (p=0.0135). There was also variation in the frequency of IL-6-174 and TNF-α-308 genotypes in the ulcerative colitis group compared with the Crohn's disease group (p=0.01). We concluded that polymorphisms in inflammatory genes are associated with variations in IBD phenotype and disease susceptibility. Whether the polymorphisms are directly involved in regulating cytokine production, and consequently pathophysiology of IBD, or serve merely as markers in linkage disequilibrium with susceptibility genes remains unclear.